Filter
254
Text search:
killer
diseases
Featured
23
77
Language
Document type
163
42
17
14
9
4
2
2
1
Countries / Regions
12
10
9
7
7
6
6
6
6
5
5
5
4
4
4
4
4
4
4
3
3
3
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
85
25
22
17
6
5
3
Toolboxes
49
26
15
12
10
9
8
7
5
5
5
4
4
3
3
2
2
2
2
1
1
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to s
...
Global UNIDO Project: Strengthening the local production of essential generic drugs in the least developed and developing countries
Accessed 25th March 2015
National AIDS and STI Control Program
From policy to practice: how the TB-HIV response is working
“The HIV community must place much more focus on TB co-infection than
it has done to date. TB takes the lives of over 1000 people living with HIV
every day, a number which is absolutely unacceptable. This report highlights that
TB d
...
Accessed November 2017
Networking for Policy Change: TB/HIV Participant’s Guide
WHO/HTM/TB/2007.384b
“TB is too often a death sentence for people with AIDS. It does not have to be this
way.”
-Nelson Mandela, International conference on HIV and AIDS, Bangkok, Thailand, July 2004.
Global Plan to end TB 2016-2020
First Edition, July 2009
Trainers’ Manual
World's largest Science, Technology & Medicine Open Access book publisher
Chapter 7 from the book People's Movements in the 21st Century - Risks, Challenges and Benefits
Journal of Pulmonary & Respiratory Medicine 6: 326. doi:10.4172/2161-105X.1000326
